The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenvatinib (len) plus pembrolizumab (pembro) in patients with advanced melanoma that progressed on anti–PD-(L)1 therapy: Over 4 years of follow-up from the phase 2 LEAP-004 study.
 
Ana Maria Arance
Consulting or Advisory Role - BioNTech SE; BMS; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - BMS; MSD; Novartis; Pierre Fabre; Roche
Research Funding - BioNTech SE (Inst); BMS (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; MSD
 
Steven J. O'Day
Employment - Agenus, Inc
Leadership - Agenus,Inc
Stock and Other Ownership Interests - Agenus,Inc
 
Luis de la Cruz-Merino
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Incyte; MSD Oncology; Roche (Inst)
Research Funding - Celgene (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Teresa M. Petrella
Honoraria - Bristol-Myers Squibb/Celgene; Merck; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Merck; Novartis; Pfizer; Sanofi
Research Funding - Pfizer
 
Rahima Jamal
Honoraria - Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Medison
Research Funding - Alkermes (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BioNTech SE (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Evelo Biosciences (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pacylex (Inst); Pfizer (Inst); Roche/Genentech (Inst); Surface Oncology (Inst); Takeda (Inst); VelosBio/Merck (Inst)
 
Lars Ny
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pierre Fabre; Sanofi; Zealth
Speakers' Bureau - Bristol-Myers Squibb/Celgene; GlaxoSmithKline; LEO Pharma; Miltenyi Biotec; MSD; Novartis; Pfizer
Research Funding - MSD (Inst); Syndax (Inst)
 
Ana Carneiro
Honoraria - BMSi; Pierre Fabre
Consulting or Advisory Role - Baxter; Merck (Inst); MSD; Novartis; Pierre Fabre; Transgene (Inst)
Expert Testimony - BMSi; Merck
 
Alfonso Berrocal-Jaime
Honoraria - Amgen; BMS; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
Consulting or Advisory Role - BMS; Merck; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech
Travel, Accommodations, Expenses - BMS; MSD
 
Ivan Marquez-Rodas
Consulting or Advisory Role - Amgen; AstraZeneca; Bioncotech; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi; Sun Pharma
Travel, Accommodations, Expenses - Bioncotech; Bristol-Myers Squibb; MSD; Pierre Fabre; Roche; Sun Pharma
 
Anna Spreafico
Honoraria - Immunocore
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; Medison; Merck
Research Funding - Alentis Therapeutics (Inst); Alkermes (Inst); ALX Oncology (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Nubiyota (Inst); Pfizer (Inst); Replimune (Inst); Roche (Inst); Seagen (Inst); SERVIER (Inst); Surface Oncology (Inst); Symphogen (Inst); Treadwell Therapeutics (Inst)
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Nektar; Novartis; Pierre Fabre; Provectus Biopharmaceuticals; QBiotics
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; QBiotics
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech
Expert Testimony - Bristol-Myers Squibb/Celgene
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; OncoSec; Pierre Fabre
 
Fernanda Costa Svedman
Employment - Npowermedicine INC (I)
Leadership - Npowermedicine INC (I)
Stock and Other Ownership Interests - Npowermedicine INC (I)
Honoraria - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck (Inst); Pfizer (Inst)
Consulting or Advisory Role - Precision medicine in Asia
Patents, Royalties, Other Intellectual Property - prognostic assay (I)
Travel, Accommodations, Expenses - Merck
 
Chinyere E Okpara
Employment - Eisai
 
Kevin Lawlor
Employment - Merck
 
Scott J. Diede
Employment - Merck
 
Tobias Neff
Employment - Merck
 
Georgina V. Long
Honoraria - BMS; Pierre Fabre
Consulting or Advisory Role - Agenus; Amgen; Array BioPharma; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Evaxion Biotech; Hexal; Highlight Therapeutics; Immunocore Ireland Limited; Innovent Biologics; IO Biotech; Merck Sharp & Dohme; Novartis; OncoSec; PHMR; Pierre Fabre; Regeneron